Академический Документы
Профессиональный Документы
Культура Документы
ANSYS Software
Marc Horner, Ph.D.
Technical Lead, Healthcare
ANSYS, Inc.
1 © 2011 ANSYS, Inc. October 24, 2011
Overview
This talk is motivated by the following observations:
1. Our understanding, and thus our ability to mathematically describe, the
human body is to the point where one can assemble human body models as
“boundary conditions” for biomedical simulations.
2. Improvements in ease‐of‐use and stability of multiphysics modeling tools.
3. Computational capabilities are continually increasing.
2 © 2011 ANSYS, Inc. October 24, 2011
Types of Human Body Models
Human Body
Modeling CARDIOVASCULAR MUSCULOSKELETAL DRUG DELIVERY EMAG
• CFD, FEA, and emag
models coupled to
lumped parameter
representations of the
human body
Parametric System
Level
• DOE for HBM
• Fully automated
process Application areas: Application areas: Application areas: Application areas:
• Coronary stents • Orthopaedic implants • Transdermal • Medical imaging
• Peripheral stents • Exercise equipment • Inhalers • Cardiology
• Artificial organs • Oral • Drug delivery
• Intrathecal • Cancer treatments
3 © 2011 ANSYS, Inc. October 24, 2011
Types of Human Body Models
Human Body
Modeling CARDIOVASCULAR MUSCULOSKELETAL DRUG DELIVERY EMAG
• CFD, FEA, and emag
models coupled to
lumped parameter
representations of the
human body
Parametric System
Level
• DOE for HBM
• Fully automated
process Application areas: Application areas: Application areas: Application areas:
• Coronary stents • Orthopaedic implants • Transdermal • Medical imaging
• Peripheral stents • Exercise equipment • Inhalers • Cardiology
• Artificial organs • Oral • Drug delivery
• Intrathecal • Cancer treatments
4 © 2011 ANSYS, Inc. October 24, 2011
Idealized Blood Flow
Material properties
Can typically assume density and viscosity at average
hematocrit and high shear.
= 1.05 g/cm3
= 0.035 g/cm-s
Inflow conditions
Literature a good source for inflow data*
vs H* vs **
Inflow conditions
Taken from on-line measurements***
* Hinghofer-Szalkay, ?? (1986)
Geometry ** Cho & Kensey, Biorheology (1991)
6
(courtesy Materialise Inc.)
© 2011 ANSYS, Inc. October 24, 2011 *** Huntsman et al., Circulation (1983)
My Flow Patterns
speed pressure
wall shear
7 © 2011 ANSYS, Inc. October 24, 2011
Outflow Conditions For Aortic Flows
One complicating factor in aortic Flow Rate Reqs for Human Organ Circuits1
flow modeling is the application
of accurate outflow boundary
conditions.
Specialized conditions are required
+5.5 L/min
because the flow split at a
bifurcation is controlled by -0.3 L/min
downstream organ demand, not
-0.8 L/min
the bifurcation geometry.
Without a specialized condition, an
-1.1 L/min
analyst will not have a proper
understanding of the baseline
-1.1 L/min
flow patterns and how an
implanted device affects those
-2.2 L/min
patterns.
Create a detailed geometric model of the
entire cardiovascular system, extending
from the heart to the capillaries. The
problems with this approach are obvious:
• Large geometric model required to
capture full geometric details
• Accuracy of the geometry will be at
question, esp. below 0.5 mm
9 © 2011 ANSYS, Inc. October 24, 2011
* Image from Texas Heart Institute web-site
Modeling Options for Outflow BCs
Electrical Circuit Model of the
Create a detailed geometric model of the Human Cardiovascular System*
entire cardiovascular system, extending
from the heart to the capillaries. The
problems with this approach are obvious:
• Large geometric model required to
capture full geometric details
• Accuracy of the geometry will be at
question, esp. below 0.5 mm
Use a lumped parameter approach to
alleviate the need for detailed geometry
at all length scales.
• The image to the right is an electrical
circuit model of the human circulatory
system, extending from the heart to
the small arteries.
• Each box contains a lumped parameter
representation of an artery section.
10 © 2011 ANSYS, Inc. October 24, 2011
* Westerhof et al., J Biomech (1969)
Lumped Parameter Model Details
The circuit on the lower left can be used to model the flow rate and
pressure losses in each artery section. This circuit is referred to as
a 3‐element Windkessel.
R RD
C
12 © 2011 ANSYS, Inc. October 24, 2011
Impedance Comparison
400.00
300.00
mag(1/E1.I)
200.00
100.00
0.00
0.00 2.00 4.00 6.00 8.00 10.00 12.00
Ansoft LLC total input imedance phase
25.00 Curve Info
-ang_deg(E1.I)
AC
-ang_deg(E1.I) [deg]
0.00
-25.00
-50.00
-75.00
0.00 2.00 4.00 6.00 8.00 10.00 12.00
F [kHz]
13 © 2011 ANSYS, Inc. October 24, 2011
Insert FLUENT into the Simplorer HBM
14 © 2011 ANSYS, Inc. October 24, 2011
Validation
‐ Flow Past a Symmetric Bifurcation
The Windkessel boundary condition was applied to an idealized representation of
the abdominal aorta. Transient values for the inlet flow rate and outlet
pressures were culled from a literature source*. The geometry and boundary
conditions were symmetric in this case. As seen in the figure on the right, there
was excellent agreement between published and computational results for the
outlet pressure.
Qin
RD = 3.22 mm Hg-s/cc
R = 0.55 mm Hg-s/cc
C = 0.001 cc/mm Hg
velocity
pressure
16 © 2011 ANSYS, Inc. October 24, 2011
Types of Human Body Models
Human Body
Modeling CARDIOVASCULAR MUSCULOSKELETAL DRUG DELIVERY EMAG
• CFD, FEA, and emag
models coupled to
lumped parameter
representations of the
human body
Parametric System
Level
• DOE for HBM
• Fully automated
process Application areas: Application areas: Application areas: Application areas:
• Coronary stents • Orthopaedic implants • Transdermal • Medical imaging
• Peripheral stents • Exercise equipment • Inhalers • Cardiology
• Artificial organs • Oral • Drug delivery
• Intrathecal • Cancer treatments
17 © 2011 ANSYS, Inc. October 24, 2011
Anybody for Implant Loads
ANSYS: FEM
analysis of a
spine implant
based on the
spine kinematics
AnyBody provides a detailed description of the loads and joint forces occurring in
the human body in daily activity. ANSYS Mechanical can import loads from Anybody,
providing critical information for testing orthopaedic implants and the like.
18 © 2011 ANSYS, Inc. October 24, 2011
Orthopaedic Workflow
Activities of daily living
Medical images
Optimization
Musculoskeletal
Simulation
Boundary
Patient conditions
information
FE-model
20 © 2011 ANSYS, Inc. October 24, 2011
Unique Open Body Model Library
21 © 2011 ANSYS, Inc. October 24, 2011
Daily Activity Analysis
22 © 2011 ANSYS, Inc. October 24, 2011
Dynamic Physiologic Loads
23 © 2011 ANSYS, Inc. October 24, 2011
In vivo validation
‐ Hip forces
Thielen et al. 2009
24 © 2011 ANSYS, Inc. October 24, 2011
A Hip Simulator
25 © 2011 ANSYS, Inc. October 24, 2011
video from: http://edp.tkk.fi/en/research/tribology/research_projects/biotribology/
Slide Track Patterns
- Slide tracks represent the relative motion of the ball and cup
27 © 2011 ANSYS, Inc. October 24, 2011
Model Inputs
dhead = 20 mm
dcup = 22 mm
Geometry
• Femur and implant provided in STL
format
• Acetabular cup was created in ANSYS
Mechanical
• Kinematic joint conditions provided by AnyBody:
140
23 Walking 120
Cycling
Angle in Degrees
13 HipAbduction 100
3 80 Flexion
HipFlexion
60 Abduction
-72.84 3.84 4.84
40 Ext. Rotation
HipExternalRot
-17 ation 20
0
-27
Time (S) -20 0 0.5 1
28 © 2011 ANSYS, Inc. October 24, 2011
Implementation
Geometry cup
• Head, cup (rigid), and stem
Material properties
stem
• Default material properties used for all parts head
Boundary Conditions
• Angular data entered as displacement BC’s for the
cup in tabular format
Solver
• ANSYS Mechanical 12.1 transient solver
• Rigid‐flexible contact maintained between the head
and the cup
Post‐processing
• Slide tracks are calculated using an APDL script which
is inserted as a command object
29 © 2011 ANSYS, Inc. October 24, 2011
Creating Slide Tracks using APDL
Choose location of the “pen”
Get the node number for the pen
location
Track the node during the transient
cycle
Report (x,y,z) vs time for the node at the
end of simulation
Use point locations to create keypoints
Join keypoints to form a spline
Display the spline with initial geometry
to see the slide tracks
30 © 2011 ANSYS, Inc. October 24, 2011
Slide Tracks on the Cup
‐ Walking Profile
31 © 2011 ANSYS, Inc. October 24, 2011
Slide Tracks on the Cup
‐ Cycling Profile
32 © 2011 ANSYS, Inc. October 24, 2011
Slide Tracks on the Cup
‐ Walking Forces
Force vs time data
3500
3000 29
2500
2000
1500
50
1000
64
500 87
0 69
2 2.2 2.4 2.6 2.8 3 3.2
-500
-1000
-1500
MediolateralForce ProximoDistalForce
AnteroPosteriorForce
3000 147
2500
2000
1500
168
1000 182
500 205
0 187
2 2.2 2.4 2.6 2.8 3 3.2
-500
-1000
-1500
MediolateralForce ProximoDistalForce
AnteroPosteriorForce
35 © 2011 ANSYS, Inc. October 24, 2011
Wear Calculation
Archard’s Law defines the effect of sliding distance (v) and
contact pressure () on the per cycle wear depth (w):
w( , ) k ( , , t ) v( , , t )dt
cycle
Which can be approximated as:
w kw S
cycle
• where,
– kw is the wear coef. (which is material and surface dependent) = 1.066E‐
6
– is the contact stress, and
– S is the sliding distance
36 © 2011 ANSYS, Inc. October 24, 2011
Cumulative Wear
(after 1 cycle)
walking cycling
wear depth reported in (mm)
37 © 2011 ANSYS, Inc. October 24, 2011
Validation
‐ Clinical Data
Hall et al (Proc Instn Mech Engrs, 1998) measured wear of
UHMWPE acetabular components retrieved from 200
patients.
38 © 2011 ANSYS, Inc. October 24, 2011
Types of Human Body Models
Human Body
Modeling CARDIOVASCULAR MUSCULOSKELETAL DRUG DELIVERY EMAG
• CFD, FEA, and emag
models coupled to
lumped parameter
representations of the
human body
Parametric System
Level
• DOE for HBM
• Fully automated
process Application areas: Application areas: Application areas: Application areas:
• Coronary stents • Orthopaedic implants • Transdermal • Medical imaging
• Peripheral stents • Exercise equipment • Inhalers • Cardiology
• Artificial organs • Oral • Drug delivery
• Intrathecal • Cancer treatments
39 © 2011 ANSYS, Inc. October 24, 2011
Pharmacokinetic (PK) Modeling
• Two boundary conditions are tested
at the far wall:
1. zero flux condition – which patch
assumes the plasma is an infinite skin
sink
2. PK condition – to account for drug microcirculation
build‐up in plasma
41 © 2011 ANSYS, Inc. October 24, 2011
Transdermal Model Details
Axisymmetry is assumed
r = 0.9 cm
Drug and enhancer are modeled as user‐defined
scalars in FLUENT patch 50.8 m
• The interfacial conditions at the patch‐skin interface are continuity of flux
and a partitioning (jump) condition:
Di , patch ci , patch Di , skin ci , skin
c drug , skin / c drug , patch K , where K is the partition coefficient
42 © 2011 ANSYS, Inc. October 24, 2011
Transdermal Model Details
‐ Formulation Effects
The permeation enhancer increases the drug flux through the
skin. The level of enhancement is typically a function of the
local enhancer concentration. Two typical situations are:
Ddrug,skin = Ddrug,0+*Cpe Kdrug,skin = Kdrug,0+*Cpe
increasing
increasing
43 © 2011 ANSYS, Inc. October 24, 2011
Validation Case
‐ Fentanyl Patch, No PK Model
Rim et al. examined the effect of enhancement type on drug
flux. These plots compare FLUENT results to their
experimental and computational results.
Comparison of drug flux through lower boundary of epidermis. Initial Comparison of drug flux through lower boundary of epidermis. Initial
concentration of drug and enhancer 0.06, 0.04(gm cm‐3). dt=100, concentration of drug and enhancer 0.06, 0.04(gm cm‐3). dt=100,
ncells=58400, µ=1.8e‐4, η=0.0 ncells=58400, µ=0.0, η=19.0
2.5 2.5
Drug Flux (µg cm‐2 hr‐1)
1.5 1.5
1.0 1.0
simulation simulation
• The ODE’s for the three
compartment PK model are:
plasma: dC ︵
p dt [ c l , t ) f u C p ( t )]
[ k el k12 k13 ] C p ( t )
k 21 2C 2 ( t ) k 31 3C3 ( t )
PK Model
dC 2 dt k12C p ( t ) / 2 k 21C2 ( t )
well-perfused
compartment:
dC 3 dt k13C p ( t ) / 3 k 31C3 ( t )
poorly perfused
compartment:
45 © 2011 ANSYS, Inc. October 24, 2011
Pharmacokinetic (PK) Analysis of a
Fentanyl Patch
• Patch model extensions:
MOTIVATION: Understand/optimize
patch performance by including the • BC between epidermis and
dermal vasculature:
physiologic processing of drug.
c
D ︵
P [c l , t) fu Cp (t)]
z
CFD Model
• The ODE’s for the three
compartment PK model are:
plasma: dC ︵
p dt [ c l , t ) f u C p ( t )]
[ k el k12 k13 ] C p ( t )
k 21 2C 2 ( t ) k 31 3C3 ( t )
PK Model
dC 2 dt k12C p ( t ) / 2 k 21C2 ( t )
well-perfused
compartment:
dC 3 dt k13C p ( t ) / 3 k 31C3 ( t )
poorly perfused
compartment:
46 © 2011 ANSYS, Inc. October 24, 2011
Types of Human Body Models
Human Body
Modeling CARDIOVASCULAR MUSCULOSKELETAL DRUG DELIVERY EMAG
• CFD, FEA, and emag
models coupled to
lumped parameter
representations of the
human body
Parametric System
Level
• DOE for HBM
• Fully automated
process Application areas: Application areas: Application areas: Application areas:
• Coronary stents • Orthopaedic implants • Transdermal • Medical imaging
• Peripheral stents • Exercise equipment • Inhalers • Cardiology
• Artificial organs • Oral • Drug delivery
• Intrathecal • Cancer treatments
47 © 2011 ANSYS, Inc. October 24, 2011
HFSS‐Workbench Link for Modeling
Cancer Treatment
Hyperthermia cancer treatment used to accelerate effects of
chemotherapy
RF power applied to tumor using phased array antenna
• Eight strip dipole antennas connected in parallel pairs and printed on
inner surface of cylindrical plastic shell
HFSS Model of Patient with Phased Array MRI Cross Section of Lower Leg with Tumor
Applicator on Lower Leg (Courtesy Duke University Medical Center)
48 © 2011 ANSYS, Inc. October 24, 2011
HFSS Model of RF Phased Array
Applicator
Device operates at 138 MHz
• Element excitations optimized to concentrate power inside tumor
• Electromagnetic power is a function of
time
– 28 W used to reach desired
temperature and 9 W to maintain
temperature
• Transient analysis used to determine
temperature rise inside tumor
– Reaches 47° C in 6 minutes and is
maintained there for 14 minutes
Results of Transient Thermal Analysis
50 © 2011 ANSYS, Inc. October 24, 2011
Closing Remarks
Coupling detailed simulations to
lumped parameter models can
provide more rigorous prediction of
device performance.
51 © 2011 ANSYS, Inc. October 24, 2011
Closing Remarks
Coupling detailed simulations to
lumped parameter models can
provide more rigorous prediction of
device performance.
V&V is possible.
,µ ,η
2.5
Pout
Drug Flux (µg cm‐2 hr‐1)
2.0
1.5
1.0
simulation
0.5 experiment
reference
0.0
0 10 20 30 40 50 60
Time (hr)
52 © 2011 ANSYS, Inc. October 24, 2011
Closing Remarks
ANSYS provides flexible and open solutions that
can be adapted to solve even the most
challenging problems facing the biomedical
engineers of today.
The ANSYS vision for this industry includes
collaborating with other software vendors
to enable one‐way and/or cosimulation
with the highest fidelity models available.
53 © 2011 ANSYS, Inc. October 24, 2011